MorphoSys is having a busy week after entering an equity participation agreement with Human Immunology Biosciences (HIBio) two days after signing a supply agreement and clinical collaboration with Pfizer and Incyte.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,